Vision

Regen Lab SA, where innovation meets medical excellence

Regen Lab : A Success Story

Together, let’s make medical innovation a reality for all. It is a vision, a passion, and a commitment to a future where cellular regeneration opens doors to even more promising medical treatments.

Manufacturing sites

Employees

%

Scientists employees

Tubes per year

The Future of Regen Lab: Reaching New Horizons

The story of Regen Lab is far from over. Building on our experience and successes, we continue to explore new ways to improve the health and well-being of patients worldwide. Our team of researchers and developers works tirelessly to innovate and push the boundaries of regenerative medicine.

Global Expansion and International Recognition

Our success knows no borders. Regen Lab has conquered international markets with a dynamic growth strategy and continuous adaptation to the specific needs of each region. Our strategic partnerships with leading medical institutions and our presence at major global conferences testify to our leadership in the field of regenerative medicine.

3 regional manufacturing footprints for direct access to regulator agencies & close to markets

NEW YORK | U.S.A

Since : Q4 2021

Employees : 50

ISO 13485 | MDSAP

 

LAUSANNE | Switzerland

Since : 2009

Employees : 75

ISO 13485 | MDSAP | EU-MDR 2017/745

 

PARIS | France

To Start in  : 2024

Employees : 40

Certification targeted in Q4 2023

 

Since 2003, Regen Lab SA has been committed to the development of a unique expertise for the design and manufa​cturing of high-quality medical devices.

Copyright © 2025 All rights reserved.

About Us

Since 2003, Regen Lab SA has specialized in designing and manufacturing high-quality medical devices for cell therapies and the preparation of autologous platelet-rich plasma (PRP) from the patient's own blood for bedside procedures.

Milestones

2003 - Foundation
2010 - RegenKit first approval in bone graft
2013 - A new state-of-theart laboratory in Lausanne
2014 - Cellular Matrix first approval
2015 - Launch of Cellular Matrix in Europe

Vision

Founded in 2003, Regen Lab has become a global reference thanks to its commitment to innovation, quality, and the effectiveness of its therapeutic solutions. Here’s how we have transformed the medical landscape over the past two decades.

RegenPRP™

RegenPRP™ is a medical treatment that uses platelet-rich plasma from the patient's own blood to enhance and tissue regeneration.

RegenPRP™ - HA

RegenPRP™ - HA combination is an innovative treatment combining platelet-rich plasma (PRP) and hyaluronic acid to improve tissue regeneration and healing.

RegenPRP™ - ATS

RegenPRP™ combined with ATS (Autologous Thrombin Serum) is an advanced approach to tissue regeneration that uses autologous thrombin-enriched platelet-rich plasma (PRP) to maximise healing effects.

RegenExtracell®

RegenExtracell is an innovative tissue regeneration treatment using an extracellular matrix enriched with platelet-rich plasma (PRP).

Hyaluronic Acid

Coming Soon

Regulatory

Manufacturers of medical devices based outside the EU must designate an Authorized Representative (EC-REP) established within the EU in order to meet the CE requirements for placing medical devices on the EU market.

Quality Management

Regen Lab Quality System Management ensures the consistency of our products quality in total GMP compliance.

Our production facility rooms atmosphere is monitored to satisfy non-pyrogenic medical devices manufacturing.

Patents

As a leader in the PRP&HA regenerative field and as an innovation-driven company, Regen Lab SA has devoted important resources since 2004 to put on the market pioneering and diversified products constituting a complete set of tools/technologies for the medical community.